Delving into the Latest Updates on Clinigen Clinical Supplies Management with Synapse

Overview

Tags

Congenital Disorders

Immune System Diseases

Endocrinology and Metabolic Disease

Bispecific T-cell Engager (BiTE)

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Hemic and Lymphatic Diseases	1
Immune System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Bispecific T-cell Engager (BiTE)	1

Top 5 Target	Count

BCMA x CD3	1

[Translation] A Phase III randomized study comparing teclistamab monotherapy with pomalidomide, bortezomib, and dexamethasone (PVd) or carfilzomib and dexamethasone (Kd) in subjects with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and lenalidomide

通过PFS评估，比较Teclistamab单药治疗与研究者选择的PVd或Kd的疗效

[Translation]

Comparison of the efficacy of teclistamab monotherapy with investigator's choice of PVd or Kd as assessed by PFS

Start Date27 Jun 2023

Sponsor / Collaborator

Clinigen Clinical Supplies Management

[+10]

CTR20221039 / Active, not recruitingPhase 3

一项在复发或难治性多发性骨髓瘤受试者中比较 Teclistamab 联合达雷妥尤单抗SC（Tec-Dara）与达雷妥尤单抗SC、泊马度胺和地塞米松（DPd）或达雷妥尤单抗 SC、硼替佐米和地塞米松（DVd）的III期随机研究

[Translation] A Phase III Randomized Study Comparing Teclistamab Plus Daratumumab SC (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma

本研究的主要目的是通过无进展生存期（PFS）评估，比较teclistamab 联合达雷妥尤单抗 SC（Tec-Dara；A 组）与研究者选择的DPd 或DVd（B 组）的疗效

[Translation]

The primary objective of this study was to compare the efficacy of teclistamab plus daratumumab SC (Tec-Dara; Group A) with investigator's choice of DPd or DVd (Group B) as assessed by progression-free survival (PFS).

Start Date27 Jun 2022

Sponsor / Collaborator

Clinigen Clinical Supplies Management

[+10]

100 Clinical Results associated with Clinigen Clinical Supplies Management

Login to view more data

0 Patents (Medical) associated with Clinigen Clinical Supplies Management

Login to view more data

100 Deals associated with Clinigen Clinical Supplies Management

Login to view more data

100 Translational Medicine associated with Clinigen Clinical Supplies Management

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data